MGRM - התחייבויות לטווח ארוך להון Monogram Orthopedics Inc.

The success of Monogram Technologies (MGRM) is based on FDA approval of new products and the pace of surgical robotization. Monogram Technologies (MGRM) stabilizes revenues by combining the sale of high-cost systems with the supply of joint consumables. Development relies on working with distributors without mergers. The indicator is 0.02. Stock price fluctuations on the GURU.Markets platform clearly demonstrate the current dynamics of this medical technology startup.

This ratio determines the proportion of long-term liabilities within the equity structure, allowing for an assessment of financial stability and the risk of excessive leverage. By analyzing the long-term debt-to-equity ratio, an investor can understand how aggressively Monogram Technologies (MGRM) is financing its expansion into the robotic orthopedics market and its capture of the hospital sector's market share through borrowed funds.